Law360 recently named the Federal Circuit’s July ruling in St. Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., an appeal from the United States Patent Trial and Appeal Board, as one of the five Biggest Patent Cases of 2018. Amin Talati Upadhye LLP attorneys submitted Comments of Amici Curiae to the PTAB […]
Ms. Roach’s practice focuses exclusively on the trademark lifecycle. Since 2006, she has counseled clients on brand selection, portfolio strategy, trademark application prosecution, brand enforcement and defense, anti-counterfeiting measures, and trademark maintenance stretching from the United States to more than 140 countries around the world. Her extensive knowledge of trademark law helps her clients secure […]
On July 9, 2018, Partners Joseph Cwik and Erin Conway earned a complete victory at the U.S. International Trade Commission (“ITC”) for the firm’s client ECI Pharmaceuticals LLC (“ECI”) when Complainants Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals International, Inc. withdrew all allegations in their Amended Complaint against ECI and moved to terminate their […]
ATU DC’s Rend Al-Mondhiry, Katie Bond, and Ivan Wasserman have been featured in a recent article published by Natural Products Insider assessing the potential issues with dietary supplement advertising by the new FTC leadership under the Republican Administration. To read the full article, please click HERE.
Shashank Upadhye will be speaking at ACI’s 12th Annual Paragraph IV Disputes conference in New York on April 23, 2018. The Paragraph IV conference is one of the biggest and most important conferences in the brand-generic drug industry. Learn more and attend the conference HERE.
Shashank Upadhye will be giving an Insight Briefing at the CPHI North America conference in Philadelphia on Tuesday, April 24, 2018. He will speak about IP/patent issues facing API and FDF companies, how to create defensible legal strategies, reduce costs, and improve licensing abilities. Learn more about the CPHI event HERE.
Law360 recently named the Federal Circuit’s July ruling in St. Regis Mohawk Tribe, et al. v. Mylan Pharmaceuticals Inc., et al., an appeal from the United States Patent Trial and Appeal Board, as one of MORE >
The content in the Amin Talati Upadhye web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Talati Upadhye or as the rendering of legal advice for any specific matter.